StockData
Anixa Biosciences Inc logo

Anixa Biosciences Inc (ANIX) stock

ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 6/30
$2.71+0.04 (+1.50%)

Close on Nov 18, 2026Market cap $94.21MP/E –Yield –

Anixa Biosciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Anixa Biosciences's revenue for the twelve months ending Oct 31, 2023 was $210.00K. For fiscal 2024 it was $210.00K, up 0.0% from the year before. Over ten years it grew -13.9% a year on average. The highest annual figure on record is $9.26M in fiscal 2015.

Annual revenue

PeriodPeriod endValueChange
FY2024Oct 31, 2024$210.00K0.0%
FY2023Oct 31, 2023$210.00K-59.0%
FY2021Oct 31, 2021$512.00K+104.8%
FY2019Oct 31, 2019$250.00K-77.5%
FY2018Oct 31, 2018$1.11M+206.9%
FY2017Oct 31, 2017$362.50K+20.8%
FY2016Oct 31, 2016$300.00K-96.8%
FY2015Oct 31, 2015$9.26M+152.4%
FY2014Oct 31, 2014$3.67M+843.1%
FY2013Oct 31, 2013$388.85K-58.6%
FY2012Oct 31, 2012$940.01K-6.3%
FY2011Oct 31, 2011$1.00M+37.3%
FY2010Oct 31, 2010$730.68K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2023CQ3 2023Oct 31, 2023$0-100.0%
Q3 FY2023CQ2 2023Jul 31, 2023$0–
Q2 FY2023CQ1 2023Apr 30, 2023$210.00K–
Q2 FY2022CQ1 2022Apr 30, 2022$0–
Q1 FY2022CQ4 2021Jan 31, 2022$513.00K0.0%
Q4 FY2021CQ3 2021Oct 31, 2021$0–
Q3 FY2021CQ2 2021Jul 31, 2021$0–
Q2 FY2021CQ1 2021Apr 30, 2021$0-100.0%
Q1 FY2021CQ4 2020Jan 31, 2021$513.00K–
Q4 FY2019CQ3 2019Oct 31, 2019$0-100.0%
Q3 FY2019CQ2 2019Jul 31, 2019$0-100.0%
Q2 FY2019CQ1 2019Apr 30, 2019$250.00K–
Q4 FY2018CQ3 2018Oct 31, 2018$0-100.0%
Q3 FY2018CQ2 2018Jul 31, 2018$362.50K+81.3%
Q2 FY2018CQ1 2018Apr 30, 2018$750.00K–
Q4 FY2017CQ3 2017Oct 31, 2017$0–
Q3 FY2017CQ2 2017Jul 31, 2017$362.50K–
Q4 FY2016CQ3 2016Oct 31, 2016$200.00K–

More Anixa Biosciences figures

See a number that looks wrong?